Type / Class
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
Shares outstanding
49.7M
Number of holders
98
Total 13F shares, excl. options
32.4M
Shares change
+8.3M
Total reported value, excl. options
$651M
Value change
+$162M
Put/Call ratio
17.38
Number of buys
56
Number of sells
-29
Price
$20.09

Significant Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q3 2023

111 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share as of Q3 2023.
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32.4M shares of 49.7M outstanding shares and own 65.16% of the company stock.
Largest 10 shareholders include Paradigm Biocapital Advisors LP (3.64M shares), Deep Track Capital, LP (3.49M shares), First Light Asset Management, LLC (2.07M shares), Jefferies Financial Group Inc. (1.95M shares), MORGAN STANLEY (1.62M shares), Point72 Asset Management, L.P. (1.3M shares), BRAIDWELL LP (1.29M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1.28M shares), Candriam S.C.A. (1.25M shares), and Polar Capital Holdings Plc (1.01M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.